Ophthalmic treatment device, system, and method of use

An ophthalmic treatment system, comprising:

• a light source device comprising at least one light source;
• a light modulating device;
• at least one optical treatment head operatively coupled to the light source device, and configured to provide at least one treatment light;
• at least one processor associated with the light source device and programmed to control operation of the light source device to provide a discontinuous treatment light projection onto a patient's eye for a selected treatment time comprising successive treatment light exposure periods of a first light intensity level separated by non-treatment periods at a second light intensity level lower than the first light intensity level;
• wherein the at least one optical treatment head projects the at least one treatment light at least two inches to the patient's eye such that a position of the at least one optical treatment head relative to the patient's eye allows physician visualization and accessibility to the patient's eye during treatment;
• wherein the at least one processor is programmed to control operation of the light modulating device of the light source device to provide the discontinuous treatment light projection onto the patient's eye;
• and
• a photosensitizer for application to the eye to promote corneal cross-linking during UVA light exposure periods, the photosensitizer comprising a riboflavin solution containing iodide ion.